Clinical Trials
  • Podcast
  • Nov 20 2020

Dr. Peter Nelson, of the University of Kentucky’s Sanders-Brown Center on Aging, has spent the last 15 years in the Commonwealth helping to lead the fight against Alzheimer’s and dementia inducing brain disease.

  • Article
  • Nov 5 2020

Janssen’s AdVac® technology was used to develop Janssen’s Ebola vaccine regimen and is the basis for its HIV, RSV and Zika vaccine candidates.

  • Article
  • Oct 29 2020

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

  • Article
  • Oct 22 2020

A team of Health Sciences investigators are collaborating with military researchers at the Naval Health Research Center and faculty at the University of Virginia to find rehabilitative solutions for populations most at risk for chronic and future ankle injuries.

  • Article
  • Sep 8 2020

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

  • Video
  • Aug 11 2020

Artemisia annua or "Sweet Annie" has been used as a medicinal herb for centuries. With potential to treat a variety of cancers & even COVID-19, this plant is more relevant than ever & UK is showing how we can take it from Kentucky fields to the lab to our patients.

  • Article
  • Aug 3 2020

UK researchers hope to gain a better understanding of the effects of COVID-19 on sleep and alcohol use so that we will be better prepared to prevent and treat psychological effects of COVID-19 pandemic or similar outbreaks in the future.

  • Article
  • Jul 29 2020

For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded Aβ plaques, by assuming that memory could be restored by removing the plaques.

  • Article
  • Jul 17 2020

This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping it will ultimately help prevent Alzheimer’s disease.

  • Article
  • Jul 16 2020

The five-year reaccreditation process involved an AAHRPP application consisting of some 1,700 pages, completed by ORI staff, describing the HRPP at UK and culminated with a two-day site visit.